4//SEC Filing
Gemphire Therapeutics Inc. 4
Accession 0001104659-16-139279
$MTVACIK 0001638287operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 1:19 PM ET
Size
8.3 KB
Accession
0001104659-16-139279
Insider Transaction Report
Form 4
LICHTINGER PEDRO
Director
Transactions
- Conversion
Common Stock
2016-08-10$6.71/sh+39,274$263,368→ 39,274 total - Conversion
8% Convertible Subordinated Promissory Note
2016-08-10→ 0 totalExercise: $6.71→ Common Stock (39,274 underlying) - Purchase
Common Stock
2016-08-10$10.00/sh+10,000$100,000→ 49,274 total
Footnotes (1)
- [F1]The note was issued in the original principal amount of $250,000. The outstanding principal and $13,370 of accrued interest on the note automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001638287
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 1:19 PM ET
- Size
- 8.3 KB